This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
A student graduating from Northern Arizona University had a high mountain to climb before graduation. Between her mothers death, the death of a friend, a shooting at her school, depression has been in her life for over a decade. With 14 anti-depressants failing to do the job, TMS was the alternative solution that felt “like a light had been turned on again.”